Chronic lymphocytic leukemia: a paradigm of innate immune cross-tolerance.
about
'Trained immunity': consequences for lymphoid malignanciesChallenges in the Role of Gammaglobulin Replacement Therapy and Vaccination Strategies for Hematological MalignancyMiR-146b Mediates Endotoxin Tolerance in Human PhagocytesA System Dynamics Model to Predict the Human Monocyte Response to Endotoxins.Ibrutinib as an antitumor immunomodulator in patients with refractory chronic lymphocytic leukemia.Circulating Monocytes Exhibit an Endotoxin Tolerance Status after Acute Ischemic Stroke: Mitochondrial DNA as a Putative Explanation for Poststroke Infections.Akt Signaling Pathway in Macrophage Activation and M1/M2 Polarization.The PD-1/PD-L1 axis contributes to immune metabolic dysfunctions of monocytes in chronic lymphocytic leukemia.Galactomannan Downregulates the Inflammation Responses in Human Macrophages via NFκB2/p100.Neutrophils from chronic lymphocytic leukemia patients exhibit an increased capacity to release extracellular traps (NETs).Chronic lymphocytic leukemia cells are active participants in microenvironmental cross-talk.Neutrophils in chronic lymphocytic leukemia are permanently activated and have functional defects.PD-L1 Overexpression During Endotoxin Tolerance Impairs the Adaptive Immune Response in Septic Patients via HIF1α.Monocyte function in patients with myelodysplastic syndrome.Thalidomide analog CC-122 induces a refractory state in monocytes from patients with diffuse large B cell lymphoma
P2860
Q28074639-9C1D4B21-1B4D-43CA-AB0E-EC03407EE828Q28080304-34849D39-D837-4195-9CEE-00E9F0173695Q38441748-765CBB88-5E27-4041-B3B8-00A4FF85CF91Q38616686-839F8E84-7C14-4C75-89D3-A774918D1C26Q38998430-70EC7920-FD4F-4AFF-B310-E883C083421FQ39003422-989DFA84-098D-49AC-9354-FA5C67A20EC5Q39099628-0406E894-43A3-4F98-8F6B-1B6E09457D3AQ39538318-700349E8-0113-4010-B86C-36E13A862478Q40461023-D1624C72-704F-4E13-9D07-01F9CB16A9C5Q40475054-3DD29501-0E93-4436-98BB-1CE05D9992DBQ46011813-738590EF-12CC-4B5C-A249-CC356D20DCC5Q46257925-40B9E2A3-86EF-4DA6-959D-BFACBEEE20DFQ47755022-A5A70692-E58B-425D-8304-7EBE0EB92DE4Q52719307-A9480363-8FBB-40BD-86E6-724A0AE36E79Q56480467-5B9A235B-2DF1-4EE6-84D7-2B84946BBA6F
P2860
Chronic lymphocytic leukemia: a paradigm of innate immune cross-tolerance.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Chronic lymphocytic leukemia: a paradigm of innate immune cross-tolerance.
@en
type
label
Chronic lymphocytic leukemia: a paradigm of innate immune cross-tolerance.
@en
prefLabel
Chronic lymphocytic leukemia: a paradigm of innate immune cross-tolerance.
@en
P2093
P50
P356
P1476
Chronic lymphocytic leukemia: a paradigm of innate immune cross-tolerance
@en
P2093
Carolina Cubillos-Zapata
Cristobal Belda
Eduardo López-Collazo
Elena Ruiz-Sainz
María Siliceo
Raúl Córdoba
Teresa Cobo
Teresa Jurado-Camino
Victor Toledano
P304
P356
10.4049/JIMMUNOL.1402272
P407
P577
2014-12-10T00:00:00Z